CBS Early Show joins ranks of zero-star health stories

Posted By

Tags

Another terribly incomplete story on a morning segment on network TV.

It was about an osteoporosis drug now being looked at for poorly healing bone fractures.

CBS put a crawl under this story reading “Stem cells to build better bones.” And then failed to mention stem cells even one time in the story.

They also had:

* No discussion of costs – which are significant.

* No discussion of evidence, which is limited.

* No discussion of the source of the information, but we can assume it was a recent study for which there was no control group to compare the results to. Furthermore, that study has not yet been published and the full results have not been reviewed by other experts. These are important caveats that the story should have mentioned.

Instead of data, the segment gushed calling it “godsend…really exciting…very important…could be lifesaving.”

Complete story review on

You might also like

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Eskimo

April 16, 2009 at 4:56 pm

Funny, the University of Rochester (more like, Eli Lilly) press release also mentions stem cells. It justifies this by saying that Forteo/teriparatide stimulates bone stem cells. Quite the marketing switcheroo!